Safe, secure blood supply

/Safe, secure blood supply
Safe, secure blood supply2018-11-23T15:22:14+00:00

The CHS advocates for access to a secure supply of the safest and most efficacious therapies for the treatment of inherited bleeding disorders.

Click here to access the Safe, secure blood supply – Report cards

Submissions on the funding of extended half‐life factor concentrates

Eloctate™ and Alprolix™, extended half-life factor VIII and factor IX for the treatment of hemophilia A and B, are approved by Health Canada. The Canadian Hemophilia Society submitted its recommendations concerning reimbursement in 2014. In 2016, both Canadian Blood Services and Héma-Québec added the two products to the list of those that could be reimbursed through their blood system budgets.

Do NOT follow this link or you will be banned from the site!